Uploaded May 2022 | Updated November 2026, 3 hours ago
As AAM journeys across the country with our Generics Are the Solution (GATS) tour, we pay a visit to Teva Pharmaceuticals USA, Inc. in Parsippany, NJ. The Teva team shares with us their commitment to patient access, safety, quality and affordability. “When a generic company wins a patent litigation, it's like David beating Goliath. The little guy wins. And what that translates to is lower healthcare costs for our patients” says Colman Ragan, Vice President & General Counsel, North America IP Litigation at Teva Pharmaceuticals.
To learn more about the generic and biosimilar medicines industry, visit accessiblemeds.org.
As AAM journeys across the country with our Generics Are the Solution (GATS) tour, we pay a visit to Teva Pharmaceuticals USA, Inc. in Parsippany, NJ. The Teva team shares with us their commitment to patient access, safety, quality and affordability. “When a generic company wins a patent litigation, it's like David beating Goliath. The little guy wins. And what that translates to is lower healthcare costs for our patients” says Colman Ragan, Vice President & General Counsel, North America IP Litigation at Teva Pharmaceuticals.
To learn more about the generic and biosimilar medicines industry, visit accessiblemeds.org.










